Status:
ENROLLING_BY_INVITATION
A Feasibility Study in Combat Athletes With Mild Traumatic Brain Injury
Lead Sponsor:
Michael Harl
Conditions:
Mild Traumatic Brain Injury (mTBI)
Brain Injury
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The use of Hyberbaric Oxygen Therapy (HBOT) would be a new treatment plan rather than conventional rest. If effective, this new use technology would add to the clinical treatment among mild traumatic ...
Eligibility Criteria
Inclusion
- 18 Years or older
- Male Unarmed Combat Athlete
- 30-day suspension (head injury without technical knockout or incapacitation)
- 60-day suspension (head injury with technical knockout or incapacitation)
- 90-day suspension (head injury with loss of consciousness)
Exclusion
- Prisoner status
- Female
- Suspension group injury severity would not include moderate to severe GCS \<13
- These suspension groups are not based on GCS; therefore, GCS is not part of the inclusion criteria. This group will be divided into randomized groups, patients who will be treated with HBOT and patients who will receive the standard of care, which is rest.
Key Trial Info
Start Date :
August 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06901310
Start Date
August 7 2025
End Date
December 31 2026
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marshfield Clinic
Marshfield, Wisconsin, United States, 54449